Interestingly, the results from these analyses identified differences in several chromatin accessible regions in genes previously associated with fate mapping and neurogenesis, which have been identified in risk determination studies focusing on cognition and autism spectrum disorders (e.g., DLK1, DIO3, IPW82,83) and ADHD (e.g., MEG384). This evidence concerns the gene DLK1 and attention deficit-hyperactivity disorder.